Abiopharma

🔍 Hays James Charles (Executive)

Company: Skyward Specialty Insurance Group, Inc. (SKWD)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 1,797 shares of Common Stock (Direct)
  Date: 2026-05-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 175,858.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-05 | Code: H | nature_of_ownership: Marquis Lafayette, LLC | shares_owned_after: 669,311.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-05 | Code: H | nature_of_ownership: JWayne, LLC | shares_owned_after: 1,975,851.00 | Footnotes: F2
• Sold 1,797 shares of 2025 RSU Award (Derivative)
  Date: 2026-05-05 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F4, F4

Footnotes:

• F1: Each Restricted Stock Unit ("RSU") settles for one share of the Issuer's Common Stock.
• F2: The Reporting Person is the controlling member of the entity.
• F3: Each RSU represents the right to receive, at settlement, one share of Common Stock of the Issuer.
• F4: On May 7, 2025, the Reporting Person was granted an RSU award of 1,797 RSUs. Subject to the terms of the award agreement, and pursuant to Board-approved accelerated vesting to coincide with the Reporting Person's director term ending at the Company's 2026 Annual Meeting of Shareholders, this award fully vested on May 5, 2026.